randomized [resa]
Evaluation [ftcn]
effects [qlco]
anacetrapib [orch, phsu]
lipid modification [moft]
Large [qnco]
Scale [medd]
randomized [resa]
placebo-controlled [resa]
Trial [resa]
effects [qlco]
anacetrapib [orch, phsu]
People [popg]
Established [qlco]
Vascular disease [dsyn]
Trial Design [inpr]
Recruitment [acty]
baseline [bodm]
Characteristics [qlco]
Patients [podg]
Prior [tmco]
Vascular disease [dsyn]
High Risk [qlco]
cardiovascular events [fndg]
Statin [orch, phsu]
Based [ftcn]
treatment [ftcn]
Inhibition [menp]
Cholesteryl Ester Transfer Protein [aapp, bacs]
anacetrapib [orch, phsu]
Low density lipoprotein [aapp, bacs, lipd]
Cholesterol [bacs, strd]
Double [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Known [qlco]
If [qlco]
Favorable [qlco]
Lipid [lipd]
translate [ocac]
reductions [npop]
cardiovascular events [fndg]
Methods [inpr]
Study [mnob]
Randomized Controlled Clinical Trial [resa]
DOUBLE BLIND [resa]
placebo [topp]
Efficacy [qlco]
Safety [hcpp]
ADD [mobd]
anacetrapib [orch, phsu]
effectiveness treatment [qlco]
lowering [spco]
atorvastatin [orch, phsu]
Average [qnco]
Patients [podg]
Pre-existing [qlco]
atherosclerotic vascular disease [dsyn]
Primary [qlco]
Assessment [hlca]
Intention [menp]
Comparison [acty]
randomized [resa]
participants [popg]
effects [qlco]
Allocation [acty]
anacetrapib [orch, phsu]
coronary [bpoc]
Events [evnt]
Defined [cnce]
occurrence [ftcn]
coronary [bpoc]
Myocardial Infarction [dsyn]
coronary revascularisation [topp]
Europe [geoa]
North America [geoa]
China [geoa]
randomized [resa]
Receive [qlco]
anacetrapib [orch, phsu]
mg% [qnco]
Daily [tmco]
MATCHING [resa]
placebo [topp]
Age [orga]
History [ocdi]
coronary heart disease [dsyn]
Cerebrovascular disease [patf]
Diabetes Mellitus [dsyn]
Randomization [resa]
Visit [bhvr]
weeks [tmco]
Protocol [inpr]
Defined [cnce]
atorvastatin [orch, phsu]
Regimen [topp]
Plasma [bdsu]
Cholesterol, LDL [bacs, strd]
mg dl [qnco]
High Density Lipoprotein Cholesterol [bacs, lipd]
mg dl [qnco]
Interpretation [inpr]
Trial [resa]
Robust [qlco]
Evaluation [ftcn]
Efficacy [qlco]
Safety [hcpp]
ADD [mobd]
anacetrapib [orch, phsu]
effective [qlco]
Statin [orch, phsu]
Regimen [topp]
